Liminatus Pharma, Inc. (LIMN)

NASDAQ: LIMN · Real-Time Price · USD
5.22
+0.66 (14.47%)
At close: May 29, 2025, 4:00 PM
5.77
+0.55 (10.54%)
After-hours: May 29, 2025, 7:57 PM EDT
14.47%
Market Cap 135.80M
Revenue (ttm) n/a
Net Income (ttm) -3.55M
Shares Out 26.01M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 10,251
Open 5.46
Previous Close 4.56
Day's Range 5.00 - 5.46
52-Week Range 4.40 - 16.44
Beta 0.25
Analysts n/a
Price Target n/a
Earnings Date n/a

About LIMN

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2018
Country United States
Stock Exchange NASDAQ
Ticker Symbol LIMN
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.